Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Esketamine for Postoperative Sleep Quality in Mastectomy
NCT06414941Recruiting
- Sponsor
- Anqing Municipal Hospital
- Start
- May 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of esketamine in Postoperative sleep disturbance (PSD) (3 arms), sponsored by Anqing Municipal Hospital. Primary endpoint: Pittsburgh Sleep Quality Index. Started May 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on NCT06414941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06414941.